Psychiatric morbidity and its recognition by doctors in patients with cancer

L Fallowfield, D Ratcliffe, V Jenkins, J Saul, L Fallowfield, D Ratcliffe, V Jenkins, J Saul

Abstract

Psychiatric morbidity in patients with cancer is high and without appropriate treatment unremitting. We assessed the ability of 143 doctors to establish the psychological status of 2297 patients during outpatient consultations in 34 cancer centres and hospitals in the UK. Prior to seeing the doctor, consenting patients completed a short self-report questionnaire (GHQ12), designed for the psychological screening of large populations. At the end of the consultation, doctors completed visual analogue scales rating patients' distress. 837/2297 (36.4%) patients had GHQ scores suggestive of psychiatric morbidity. The doctors' sensitivity (true positive rate) was 28.87% (SD 25.29), specificity (true negative rate) 84.79% (SD 17.44). The misclassification rate was 34.7% (SD 13.79) meaning that for 797 patients the wrong assessment was probably made. These data show that much of the probable psychiatric morbidity experienced by patients with cancer goes unrecognized and therefore untreated. Doctors need communication skills training to elicit problems during consultations. Appropriate referrals to psychological services are necessary when patients requiring help are identified and ought to be an integral part of cancer care.

Copyright 2001 Cancer Research Campaign.

References

    1. Behav Med. 1990 Spring;16(1):15-22
    1. J Psychosom Res. 1989;33(2):235-9
    1. BMJ. 1990 Sep 22;301(6752):575-80
    1. Br J Cancer. 1991 Aug;64(2):353-6
    1. J Clin Oncol. 1991 Oct;9(10):1916-20
    1. Psychol Med. 1993 Feb;23(1):185-93
    1. Br J Cancer. 1994 Oct;70(4):767-70
    1. BMJ. 1994 Aug 13;309(6952):448
    1. Support Care Cancer. 1995 Jan;3(1):45-60
    1. CMAJ. 1995 May 1;152(9):1423-33
    1. Br J Cancer. 1995 Jun;71(6):1263-9
    1. Health Psychol. 1995 Mar;14(2):101-8
    1. Arch Intern Med. 1995 Sep 25;155(17):1877-84
    1. BMJ. 1995 Nov 18;311(7016):1316-7
    1. Lancet. 1996 Mar 16;347(9003):724-8
    1. Soc Sci Med. 1996 Jun;42(11):1511-9
    1. Palliat Med. 1997 Jul;11(4):283-90
    1. J Clin Oncol. 1998 Apr;16(4):1594-600
    1. J Clin Oncol. 1998 May;16(5):1961-8
    1. Cancer. 1998 Oct 15;83(8):1640-51
    1. J Clin Oncol. 1999 Mar;17(3):998-1007
    1. Cancer. 1999 Sep 1;86(5):887-97
    1. Br J Cancer. 1999 Aug;80(11):1770-80
    1. Psychooncology. 1999 Jul-Aug;8(4):315-33
    1. J Fam Pract. 1999 Dec;48(12):949-57
    1. J Fam Pract. 1999 Dec;48(12):958-64
    1. J Clin Oncol. 2000 Feb;18(4):893-903
    1. Eur J Cancer. 1999 Dec;35(14):2058-65
    1. Br Med J. 1978 Apr 15;1(6118):963-5
    1. JAMA. 1983 Feb 11;249(6):751-7
    1. J Clin Psychiatry. 1990 Jul;51 Suppl:12-7; discussion 18-9

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe